Glycation of glucagon-like peptide- 1(7-36)amide: Characterization and impaired action on rat insulin secreting cells

Diabetologia

Volumn 41, Issue 10, 1998, Pages 1187-1193

  O'Harte, F P M ^a   Abdel Wahab, Y H A ^a   Conlon, J M ^b   Flatt, P R ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRIN BD11 cells; GLP 1(7 36)amide; Glycation; Insulin secretion

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCOSE; INSULIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLYCATION; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; GLYCOSYLATION; INSULIN; INTESTINE, SMALL; ISLETS OF LANGERHANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RADIOIMMUNOASSAY; RATS; SEQUENCE ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031721266     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051050     Document Type: Article

References (46)

1. Creutzfeldt W, Ebert R (1985) New development in the incretin concept. Diabetologia 28: 565-573
2. Fehmann H-C, Göke R, Göke B (1995) Cell and molecular biology of the incretin hormones glucagon-like peptide-1 and glucose-dependent insulin releasing polypeptide. Endocr Rev 16: 390-410
3. Holst JJ, Ørskov C (1994) Glucagon and other proglucagon-derived peptides. In: Walsh JH, Dockray GJ (eds) Gut Peptides Biochemistry and Physiology, Raven Press Ltd., New York, pp 305-340
4. Goke B, Goke R, Fehmann H-C, Bode H-P (1996) Physiology and pathophysiology of GLP-1. In: Lefèbvre P J (ed) Glucagon III, Springer-Verlag, Berlin, pp 275-309
5. Nauck M (1996) Therapeutic potential of glucagon-like peptide 1 in type 2 diabetes. Diabet Med 13:S39-S43
6. Hvidberg A, Nielsen MT, Hilsted J, Ørskov C, Holst JJ (1994) Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism 43: 104-108
7. Villanueva-Peñacarrillo ML, Alcántara AI, Clemente F, Delgado E, Valverde I (1994) Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle. Diabetologia 37: 1163-1166
8. Fürnsinn C, Ebner K, Waldhäusl W (1995) Failure of GLP-1(7-36)amide to affect glycogenesis in rat skeletal muscle. Diabetologia 38: 864-867
9. Nauck MA, Holst JJ, Willms B, Schmiegel W (1997) Glucagon-like peptide 1 (GLP-1) a new therapeutic approach for type 2-diabetes. Exp Clin Endocrinol Diabetes 105: 187-194
10. O'Harte FPM, Gray AM, Abdel-Wahab YHA, Flatt PR (1997) Effects of non-glycated and glycated glucagon-like peptide-1(7-36)amide on glucose metabolism in isolated mouse abdominal muscle. Peptides 18: 1327-1333
11. Gutniak M, Ørskov C, Holst JJ, Ahrén B, Efendic S (1992) Antidiabetogenic effect of glucagon-like peptide 1 (7-36)amide in normal subjects and patients with diabetes mellitus. New Engl J Med 326: 1316-1322
12. Göke R, Trautmann ME, Haus E et al. (1989) Signal transmission after GLP-1(7-36)amide binding in RINm5F cells. Am J Physiol 257:G397-G401
13. Fehmann HC, Habener JF (1991) Homologous desensitization of the insulinotropic glucagon-like peptide-1(7-37) receptor on insulinoma (HIT-T15) cells. Endocrinology 128: 2880-2888
14. Wheeler MB, Lu M, Dillon SJ, Leng XH, Chen C, Boyd III AE (1993) Functional expression of the rat glucagon-like peptide-1 receptor, evidence for coupling to both adenylyl cyclase and phospholipase C. Endocrinology 133: 57-62
15. Clark SA, Burnham BL, Chick WL (1990) Modulation of glucose-induced insulin secretion from a rat clonal cell line. Endocrinology 127: 2779-2788
16. Göke R, Conlon JM (1988) Receptors for glucagon-like peptide-1(7-36)amide on rat insulinoma-derived cells. J Endocrinol 116: 357-362
17. Lankat-Buttgereit B, Göke R, Stöckmann F, Fehmann HC, Göke B (1994) Detection of the human GLP-1(7-36)amide receptor on insulinoma-derived cell membranes. Digestion 55: 29-33
18. Thorens B, Porret A, Bühler L, Deng S-P, Morel P, Widmann C (1993) Cloning and functional expression of the human islet GLP-1 receptor: demonstration that exendin-4 is an agonist and exendin-(9-39) antagonist of the receptor. Diabetes 42: 1678-1682
19. Ørskov C, Poulsen SS (1991) Autoradiography of rat tissues with GLP-1. Diabetes 40: 1292-1296
20. McClenaghan NH, Barnett CR, Ah-Sing E et al. (1996) Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion. Diabetes 45: 1132-1140
21. O'Harte FPM, Højrup P, Barnett CR, Flatt PR (1996) Identification of the site of glycation of human insulin. Peptides 17: 1323-1330
22. Abdel-Wahab YHA, O'Harte FPM, Ratcliff H, McClenaghan NH, Barnett CR, Flatt PR (1996) Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes 45: 1489-1496
23. Abdel-Wahab YHA, O'Harte FPM, Barnett CR, Flatt PR (1997) Characterization of insulin glycation in insulin-secreting cells maintained in tissue culture. J Endocrinol 152: 59-67
24. Roepstorff P (1993) 252-Californium plasma desorption time-of-flight mass spectrometry of peptides and proteins. Methods Mol Biol 17: 229-235
25. O'Harte FPM, Bockman CS, Abel PW, Conlon JM (1991) Isolation, structural characterization and pharmacological activity of dog neuromedin U. Peptides 12: 11-15
26. Flatt PR, Bailey CJ (1981) Abnormal plasma glucose and insulin responses in heterozygous lean (ob/ + ) mice. Diabetologia 20: 573-577
27. Shima K, Hirota M, Ohboshi C (1988) Effect of glucagon-like peptide-1 on insulin secretion. Regul Pept 22: 245-250
28. Komatsu R, Matsuyama T, Namba M (1989) Glucagonostatic and insulinotropic action of glucagon-like peptide-1(7-36)-amide. Diabetes 38: 902-905
29. Weir GC, Mojsov S, Hendrick GK, Habener JF (1989) Glucagon-like peptide-1(7-37) actions on endocrine pancreas. Diabetes 38: 338-342
30. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF (1987) Glucagon-like peptide-1 stimulates insulin gene expression and increases cyclic AMP levels in a rat cell line. Proc Natl Acad Sci USA 84: 3434-3438
31. Lu M, Wheeler MB, Leng XH, Boyd III AE (1993) The role of the free calcium level in β-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide-1(7-37). Endocrinology 132: 94-100
32. 2+ channel activity. Endocrinology 133: 1685-1692
33. Gromada J, Dissing S, Bokvist K et al. (1995) Glucagon-like peptide 1 increases cytoplasmic calcium in insulin secreting beta-TC3-cells by enhancement of intracellular calcium mobilization. Diabetes 44: 767-774
34. Holz IV, Kuhtreiber WM, Habener JF (1993) Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361: 362-365
35. Rachmann J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC (1996) Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide-1(7-36)amide in patients with NIDDM. Diabetes 45: 1524-1530
36. Kawai K, Suzuki S, Ohashi S (1989) Comparison of the effects of glucagon-like peptide-1(1-37) and glucagon-like peptide-1(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases. Endocrinology 124: 1768-1772
37. Flatt PR, Abdel-Wahab YHA, Boyd AC, Barnett CR, O'Harte FPM (1996) Pancreatic B-cell dysfunction and glucose toxicity in non-insulin-dependent diabetes. Proc Nutr Soc 56: 243-262
38. Suzuki S, Kawai K, Ohashi S (1989) Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide 1 on insulin and glucagon release from isolated perfused rat pancreas. Endocrinology 125: 3109-3114
39. Mojsov S (1992) Structural requirements for biological activity of glucagon-like peptide-1. Int J Peptide Protein Res 40: 333-343
40. Adelhorst K, Hedegaard BB, Knudsen B, Kirk OD (1994) Structure activity studies of glucagon-like peptide-1. J Biol Chem 269: 6275-6278
41. Deacon CF, Knudsen LB, Madsen K, Wiberg FC, Jacobsen O, Holst JJ (1998) Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity. Diabetologia 41: 271-278
42. Mooney M, Kelly CMN, Flatt PR, O'Harte FPM (1998) Aminopeptidase resistant glycated glucagon-like peptide-1(7-36)amide shows potent insulinotropic action in vivo. Diabetologia 41: A 183 (Abstracts)
43. Kieffer TJ, McIntosh CHS, Pedersen RA (1995) Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide-1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136: 3585-3596
44. Deacon CF, Johnsen AH, Holst JJ (1995) Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous peptide in vivo. J Clin Endocrinol Metab 80: 952-957
45. Gefel D, Hendrick GK, Mojsov S, Habener J, Weir GC (1990) Glucagon-like peptide-1 analogs: effects on insulin secretion and 3′,5′-monophosphate formation. Endocrinology 126: 2164-2168
46. Grandt D, Sieburg B, Schimiczek M et al. (1994) Is GLP-1(9-36)amide an endogenous antagonist at GLP-1 receptors. Digestion 55: 302 (Abstract)